DRG Market Assessment reports

Asthma treatment generally includes rescue therapy to relieve acute exacerbations and maintenance therapy to prevent future attacks. A wide array of well-established therapies spanning multiple…

Asthma is a chronic inflammatory disorder of the airways affecting millions of people across the EU5 countries under study and representing a costly health expense for payers. Symptoms can often be…

The U.S. asthma therapy market has long been dominated by several effective and well-established treatments, including inhaled and oral therapies, but following the recent approval of two biologics…

Although several effective anti-inflammatory agents and bronchodilators are currently available for controlling disease in mild asthmatics, unmet needs exist in treating moderate to severe disease…

Although several effective anti-inflammatory agents and bronchodilators are currently available for controlling disease in mild asthmatics, unmet needs exist in treating moderate to severe disease…

Emerging Therapies: Nucala (US) is a three-wave syndicated detailed expanded analysis that specifically tracks the introduction of Nucala, the first IL-5 inhibitor approved to treat eosinophilic…

Emerging Therapies: Nucala (US) is a three-wave, syndicated, detailed, expanded analysis that tracks the introduction of Nucala, the first IL-5 inhibitor approved to treat eosinophilic asthma. The…

For the estimated 14.5 million diagnosed prevalent cases of asthma in the United States, there are multiple prescription therapies that are available for treating the associated symptoms. The…

Increasing formulary competition and decreasing product differentiation have led to an aggressive pricing war in the U.S. asthma and chronic obstructive pulmonary disorder (COPD) markets. As…

Last Updated 21 September 2015 The asthma market has historically been one of the most lucrative drug markets in the pharmaceutical industry owing to a large and growing patient population…

Physician and Payer Perspectives on Prescribing and Patient Access China has long wrestled with an increasing prevalence in respiratory diseases that has accompanied its economic growth and…

Can Targeting Patient Subpopulations Serve as a Market Access Lever? The asthma market is dominated by a number of effective and well-established treatments, including inhaled and oral therapies…